marbofloxacin has been researched along with Canine Diseases in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (19.23) | 18.2507 |
| 2000's | 11 (42.31) | 29.6817 |
| 2010's | 10 (38.46) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kietzmann, M; Mielke, S; Pankow, WR; Stahl, J | 1 |
| Appelboam, H; Guerreiro, CE; Lowe, RC | 1 |
| Boulouis, HJ; El Garch, F; Galland, D; Kroemer, S; Petit, JL; Woehrle, F | 1 |
| Seymour, CJ; Stathopoulou, TR | 1 |
| Jerzsele, Á; Pásztiné-Gere, E | 1 |
| Beyerbach, M; Hoppe, S; Kästner, SB; Pankow, WR; Tipold, A; Tünsmeyer, J; Weil, C | 1 |
| Choi, MJ; Damte, D; Gebru, E; Lee, SJ; Park, SC | 1 |
| Choi, MJ; Damte, D; Gebru, E; Kim, YH; Lee, SJ; Park, SC | 1 |
| Delaunay, P; Hasseine, L; Marty, P; Michel, G; Rougier, S | 1 |
| Badino, P; Farca, AM; Ferroglio, E; Miniscalco, B; Monticelli, P; Odore, R; Trisciuoglio, A | 1 |
| Boisramé, B; Concordet, D; Regnier, A; Schneider, M; Toutain, PL | 1 |
| Horspool, LJ; Mawhinney, I; van den Bos, R; van Laar, P | 1 |
| Acar, JF; Kroemer, S; Martel, JL; Meunier, D; Valle, M | 1 |
| Boisramé, B; Borell, D; Pheulpin, S; Rougier, S; Woehrlé, F | 1 |
| Dugas, B; Mazier, D; Pino, P; Rougier, S; Vouldoukis, I; Woehrlé, F | 1 |
| Bensignor, E; Grandemange, E | 1 |
| Cavana, P; Farca, AM; Nebbia, P; Robino, P | 1 |
| Concordet, D; Regnier, A; Schneider, M; Toutain, PL | 1 |
| Fournel, S; Pérès, S; Rougier, S; Vouldoukis, I; Woehrlé, F | 1 |
| Cotard, JP; Deleforge, J; Gruet, P; Moreau, P; Pages, JP; Pechereau, D; Thomas, E | 1 |
| Boisramé, B; Deleforge, J; Drugeon, H; Spreng, M; Thomas, V | 1 |
| Dupouy, V; Laroute, V; Lefebvre, HP; Schneider, M; Toutain, PL | 1 |
| Costes, G; Delesalle, L; Dupouy, V; Laroute, V; Lefebvre, HP; Schneider, M; Toutain, PL | 1 |
| Carlotti, DN; Guaguere, E; Guiral, V; Jasmin, P; Pin, D; Thomas, E | 1 |
| González Lama, Z; Lupiola Gómez, P; Martín Barrasa, JL; Tejedor Junco, MT | 1 |
| Abbey, L; Baker, B; Coyne, M; Hannigan, M; Joffe, D; Paradis, M; Pukay, B; Trettien, A; Waisglass, S; Wellington, J | 1 |
7 trial(s) available for marbofloxacin and Canine Diseases
| Article | Year |
|---|---|
Effects of concurrent perioperative use of marbofloxacin and cimicoxib or carprofen in dogs.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Dog Diseases; Dogs; Drug Interactions; Drug Therapy, Combination; Electroencephalography; Female; Fluoroquinolones; Imidazoles; Intraoperative Care; Male; Nervous System Diseases; Perioperative Period; Prospective Studies; Sulfonamides | 2016 |
Population pharmacokinetics of marbofloxacin in aqueous humor after intravenous administration in dogs.
Topics: Animals; Anti-Infective Agents; Aqueous Humor; Dog Diseases; Dogs; Eye Diseases; Female; Fluoroquinolones; Half-Life; Injections, Intravenous; Male; Quinolones | 2003 |
Treatment of canine pyoderma with ibafloxacin and marbofloxacin--fluoroquinolones with different pharmacokinetic profiles.
Topics: Administration, Oral; Animals; Dog Diseases; Dogs; Drug Administration Schedule; Europe; Fluoroquinolones; Pyoderma; Quinolizines; Quinolones; Severity of Illness Index; Treatment Outcome; Veterinary Drugs | 2004 |
A comparative study of two antimicrobial/anti-inflammatory formulations in the treatment of canine otitis externa.
Topics: Administration, Topical; Animals; Anti-Infective Agents, Local; Anti-Inflammatory Agents; Clotrimazole; Dexamethasone; Dog Diseases; Dogs; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Male; Microbial Sensitivity Tests; Otitis Externa; Quinolones; Treatment Outcome | 2005 |
Efficacy of different treatment regimens of marbofloxacin in canine visceral leishmaniosis: a pilot study.
Topics: Administration, Oral; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Enzyme Inhibitors; Female; Fluoroquinolones; Follow-Up Studies; Leishmaniasis, Visceral; Male; Pilot Projects; Recurrence; Time Factors; Treatment Outcome | 2008 |
Comparative study of marbofloxacin and amoxicillin-clavulanic acid in the treatment of urinary tract infections in dogs.
Topics: Administration, Oral; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Infective Agents; Bacteria; Clavulanic Acids; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Fluoroquinolones; Injections, Subcutaneous; Male; Quinolones; Recurrence; Treatment Outcome; Urinary Tract Infections | 1995 |
Therapy of difficult cases of canine pyoderma with marbofloxacin: a report of 39 dogs.
Topics: Animals; Anti-Infective Agents; Body Weight; Cellulitis; Dog Diseases; Dogs; Enzyme Inhibitors; Erythema; Female; Fluoroquinolones; Folliculitis; Follow-Up Studies; Male; Microbial Sensitivity Tests; Pruritus; Pyoderma; Quinolones; Recurrence; Skin Ulcer; Staphylococcal Infections; Treatment Outcome | 1999 |
19 other study(ies) available for marbofloxacin and Canine Diseases
| Article | Year |
|---|---|
Ceruminal diffusion activities and ceruminolytic characteristics of otic preparations - an in-vitro study.
Topics: Animals; Azo Compounds; Cerumen; Diffusion; Dog Diseases; Dogs; Female; Fluoroquinolones; In Vitro Techniques; Male; Otitis Externa | 2013 |
Successful medical treatment for globe penetration following tooth extraction in a dog.
Topics: Animals; Anti-Inflammatory Agents; Atropine; Carbonic Anhydrase Inhibitors; Dog Diseases; Dogs; Eye Injuries, Penetrating; Fluoroquinolones; Male; Mydriatics; Prednisolone; Sulfonamides; Thiazines; Tooth Extraction | 2014 |
Antibiotic susceptibility of bacteria isolated from infections in cats and dogs throughout Europe (2002-2009).
Topics: Animals; Anti-Bacterial Agents; Cat Diseases; Cats; Dog Diseases; Dogs; Drug Resistance, Multiple, Bacterial; Epidemiological Monitoring; Europe; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Otitis; Respiratory Tract Infections; Skin Diseases, Bacterial; Treatment Outcome; Urinary Tract Infections | 2014 |
An adverse reaction to intravenously administered marbofloxacin in a dog during general anaesthesia.
Topics: Anesthesia, General; Animals; Anti-Bacterial Agents; Dog Diseases; Dogs; Drug Hypersensitivity; Fluoroquinolones; Hypotension; Male; Sodium Lactate; Tachycardia; Tachypnea | 2015 |
Evaluating synergy between marbofloxacin and gentamicin in Pseudomonas aeruginosa strains isolated from dogs with otitis externa.
Topics: Animals; Anti-Bacterial Agents; Dog Diseases; Dogs; Drug Synergism; Fluoroquinolones; Gentamicins; Microbial Sensitivity Tests; Otitis Externa; Pseudomonas aeruginosa; Pseudomonas Infections | 2015 |
Mutant-prevention concentration and mechanism of resistance in clinical isolates and enrofloxacin/marbofloxacin-selected mutants of Escherichia coli of canine origin.
Topics: Animals; Anti-Bacterial Agents; DNA, Bacterial; Dog Diseases; Dogs; Drug Resistance, Bacterial; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Male; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Selection, Genetic; Sequence Analysis, DNA; Time Factors | 2011 |
Mutant prevention concentration and phenotypic and molecular basis of fluoroquinolone resistance in clinical isolates and in vitro-selected mutants of Escherichia coli from dogs.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Base Sequence; Ciprofloxacin; Dog Diseases; Dogs; Drug Resistance, Bacterial; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation | 2012 |
One-year clinical and parasitological follow-up of dogs treated with marbofloxacin for canine leishmaniosis.
Topics: Animals; Anti-Bacterial Agents; Dog Diseases; Dogs; Drug Administration Schedule; Enzyme-Linked Immunosorbent Assay; Female; Fluoroquinolones; Leishmaniasis; Male; Real-Time Polymerase Chain Reaction; Serologic Tests | 2012 |
Canine leishmaniosis: in vitro efficacy of miltefosine and marbofloxacin alone or in combination with allopurinol against clinical strains of Leishmania infantum.
Topics: Allopurinol; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Drug Synergism; Fluoroquinolones; Leishmania infantum; Leishmaniasis, Visceral; Phosphorylcholine | 2012 |
A seven-year survey of susceptibility to marbofloxacin of pathogenic strains isolated from pets.
Topics: Animals; Animals, Domestic; Cat Diseases; Cats; Data Collection; Dog Diseases; Dogs; Drug Resistance, Bacterial; Escherichia coli; Fluoroquinolones; Microbial Sensitivity Tests; Quinolones | 2004 |
Canine visceral leishmaniasis: comparison of in vitro leishmanicidal activity of marbofloxacin, meglumine antimoniate and sodium stibogluconate.
Topics: Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fibroblasts; Fluoroquinolones; Interleukin-6; Leishmania infantum; Leishmaniasis, Visceral; Macrophages; Meglumine; Meglumine Antimoniate; Mice; Nitric Oxide; Organometallic Compounds; Parasitic Sensitivity Tests; Quinolones; Tumor Necrosis Factor-alpha | 2006 |
Comparison of an antifungal agent with a mixture of antifungal, antibiotic and corticosteroid agents for the treatment of Malassezia species otitis in dogs.
Topics: Administration, Topical; Adrenal Cortex Hormones; Animals; Anti-Bacterial Agents; Antifungal Agents; Chi-Square Distribution; Clotrimazole; Dermatomycoses; Dexamethasone; Dog Diseases; Dogs; Drug Combinations; Female; Fluoroquinolones; Malassezia; Male; Miconazole; Otitis Externa; Quinolones; Treatment Outcome | 2006 |
In vitro antimicrobial activity of marbofloxacin and enrofloxacin against bacterial strains isolated from companion animals.
Topics: Animals; Anti-Bacterial Agents; Cat Diseases; Cats; Colony Count, Microbial; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Enrofloxacin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Quinolones; Treatment Outcome | 2007 |
Intraocular pharmacokinetics of intravenously administered marbofloxacin in rabbits with experimentally induced acute endophthalmitis.
Topics: Animals; Anti-Infective Agents; Aqueous Humor; Area Under Curve; Disease Models, Animal; Dog Diseases; Dogs; Endophthalmitis; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Half-Life; Injections, Intravenous; Male; Quinolones; Rabbits; Vitreous Body | 2008 |
Antibacterial activity of marbofloxacin. A new fluoroquinolone for veterinary use against canine and feline isolates.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacteriuria; Cat Diseases; Cats; Dog Diseases; Dogs; Enzyme Inhibitors; Escherichia coli; Fluoroquinolones; Microbial Sensitivity Tests; Pasteurella multocida; Quinolones; Staphylococcus; Staphylococcus aureus; Topoisomerase II Inhibitors | 1995 |
Pharmacokinetics of marbofloxacin in renal impairment in the dog.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Dog Diseases; Dogs; Female; Fluoroquinolones; Quinolones; Renal Insufficiency | 1998 |
Effect of experimental renal impairment on disposition of marbofloxacin and its metabolites in the dog.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Area Under Curve; Creatinine; Dog Diseases; Dogs; Female; Fluoroquinolones; Glomerular Filtration Rate; Injections, Intravenous; Quinolones; Renal Insufficiency; Urea | 1998 |
Antibacterial susceptibility patterns of Pseudomonas strains isolated from chronic canine otitis externa.
Topics: Animals; Anti-Bacterial Agents; Ceftazidime; Chronic Disease; Dog Diseases; Dogs; Drug Resistance, Microbial; Fluoroquinolones; Microbial Sensitivity Tests; Otitis Externa; Pseudomonas; Pseudomonas Infections; Quinolones; Tobramycin | 2000 |
Evaluation of the clinical efficacy of marbofloxacin (Zeniquin) tablets for the treatment of canine pyoderma: an open clinical trial.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Breeding; Canada; Dog Diseases; Dogs; Female; Fluoroquinolones; Male; Pyoderma; Quinolones; Severity of Illness Index; Staphylococcal Infections; Treatment Outcome | 2001 |